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Self-renewal of pluripotent mouse embryonic stem (ES)
cells is sustained by the cytokine leukaemia inhibitory
factor (LIF) acting through the transcription factor Stat3.
Several targets of Stat3 have previously been identiﬁed,
most notably the reprogramming factor Klf4. However,
such factors are neither required nor sufﬁcient for the
potent effect of LIF. We took advantage of Stat3 null ES
cells to conﬁrm that Stat3 mediates the self-renewal
response to LIF. Through comparative transcriptome ana-
lysis intersected with genome location data, we arrived at
a set of candidate transcription factor effectors. Among
these, Tfcp2l1 (also known as Crtr-1) was most abundant.
Constitutive expression of Tfcp2l1 at levels similar to those
induced by LIF effectively substituted for LIF or Stat3
in sustaining clonal self-renewal and pluripotency.
Conversely, knockdown of Tfcp2l1 profoundly compro-
mised responsiveness to LIF. We further found that
Tfcp2l1 is both necessary and sufﬁcient to direct molecular
reprogramming of post-implantation epiblast stem cells
to naı¨ve pluripotency. These results establish Tfcp2l1 as
the principal bridge between LIF/Stat3 input and the
transcription factor core of naı¨ve pluripotency.
The EMBO Journal (2013) 32, 2561–2574. doi:10.1038/
emboj.2013.177; Published online 13 August 2013
Subject Categories: signal transduction; development
Keywords: ES cell self-renewal; LIF; pluripotency;
reprogramming
Introduction
Early mammalian embryos are characterized by the presence
of a regulative population of cells each with the capability of
giving rise to all somatic lineages and to germ cells. This
property, pluripotency, ﬁrst emerges in a naı¨ve form in the
epiblast in the pre-implantation blastocyst (Nichols and
Smith, 2012). When exposed to an appropriate environment
ex vivo, mouse naı¨ve epiblast cells can be expanded
indeﬁnitely as embryonic stem (ES) cells (Evans and
Kaufman, 1981; Martin, 1981; Nichols et al, 1990; Brook
and Gardner, 1997). The cytokine leukaemia inhibitory
factor (LIF) potently promotes ES cell self-renewal (Smith
et al, 1988; Williams et al, 1988), and is routinely used in the
derivation and culture of mouse ES cells (Smith, 2001).
Binding of LIF to the gp130/LIF-R complex leads to
activation of JAK kinases (Yoshida et al, 1994) that, in turn,
phosphorylate the transcription factor Stat3 (Akira et al,
1994; Boeuf et al, 1997). Phosphorylated Stat3 dimerizes,
enters the nucleus, and activates the expression of target
genes (Zhong et al, 1994; Boeuf et al, 1997; Burdon et al,
2002; Bourillot et al, 2009). Artiﬁcial activation of Stat3 is
sufﬁcient to sustain ES cell self-renewal in the absence of LIF
(Burdon et al, 1999; Matsuda et al, 1999), whereas
antagonism of Stat3 leads to differentiation (Niwa et al,
1998; Bourillot et al, 2009). These ﬁndings indicate that
Stat3 is the key mediator of LIF action in ES cells. However,
LIF activates via JAK other signalling pathways that have also
been proposed to play a role in ES cell maintenance (Welham
et al, 2007; Niwa et al, 2009; Grifﬁths et al, 2011).
LIF/Stat3 signalling also plays a key role in the conversion
of primordial germ cells into pluripotent EG cells (Matsui
et al, 1992; Resnick et al, 1992; Leitch et al, 2013) and
facilitates transcription factor directed reprogramming.
Hyperactivation of Stat3 potently enhances reprogramming
of somatic cells into induced pluripotent stem (iPS) cells (van
Oosten et al, 2012), while blockade of the LIF/Stat3 pathway
abolishes iPS cell generation (Tang et al, 2012). Furthermore,
post-implantation epiblast stem cells, EpiSCs (Brons et al,
2007; Tesar et al, 2007), can be reprogrammed to a naı¨ve
pluripotent state simply by transient activation of Stat3 (Yang
et al, 2010). These actions are separable from the self-renewal
effect of LIF/Stat3 on established pluripotent stem cells (Yang
et al, 2010).
Despite the central role ascribed to Stat3 in mouse pluripo-
tency, its downstream effectors are incompletely described. LIF
does not directly regulate core pluripotency factors Oct4, Sox2,
Nanog, or Esrrb. Efforts to delineate the transcriptional pro-
gramme stimulated by LIF have identiﬁed transcription factor
targets of Stat3, such as Klf4, Pim1, and Gbx2 (Li et al, 2005;
Hall et al, 2009; Niwa et al, 2009; Tai and Ying, 2013). However,
none of these factors are indispensable for LIF responsiveness,
nor can their forced expression fully recapitulate LIF activity.
Notably, Klf4 is one of the four canonical Yamanaka factors that
direct somatic cell reprogramming (Takahashi and Yamanaka,
2006), but LIF is required in addition (Tang et al, 2012).
These observations suggest either, functional redundancy and
additive effects between multiple Stat3 targets, or alternatively
the existence of a pivotal unidentiﬁed target.
We previously showed that two selective small molecule
inhibitors (2i) of Gsk3 and Mek kinases eliminate ES cell
differentiation and can sustain self-renewal in the absence
of LIF (Ying et al, 2008; Wray et al, 2010). Furthermore,
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2i allows derivation and expansion of Stat3 / ES cells.
Here, we exploited these null cells in a reﬁned search for
critical effectors of the LIF/Stat3 pathway.
Results
Loss of Stat3 has no effect on potency of ES cells
Stat3 null ES cells can be derived and expanded when
differentiation stimuli are blocked using 2i (Ying et al,
2008). We conﬁrmed the identity and pluripotency of these
cells by chimaera formation after blastocyst injection
(Figure 1A). Consistent with this, when we examined the
expression of genes associated with either pluripotency or
germ layer speciﬁcation we found no major differences
between Stat3 null and wild-type cells maintained in 2i
(Figure 1B). Furthermore, null cells did not exhibit any
overt sign of spontaneous differentiation or appreciable cell
death (Figure 1C) and were able to generate undifferentiated
colonies at clonal density with efﬁciency equal to wild-type
cells (Figure 1D). We therefore conclude that deletion of
Stat3 does not impair ES cell self-renewal efﬁciency in 2i.
In other culture conditions, however, the mutant cells cannot
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Figure 1 Absence of Stat3 does not alter ES cell identity, pluripotency, or self-renewal in 2i. (A) GFP-labelled Stat3 / ES cells were injected
into blastocyst stage embryos; embryos were scored at E9.5 for the presence of GFP-positive cells and 15 embryos out of 19 showed widespread
chimaerism. At mid-gestation (E12.5), 3 out of 3 embryos showed widespread chimaerism (not shown). A representative chimaeric embryo at
E9.5 is shown. The embryo on the right showed no chimaerism and serves as a control for autoﬂuorescence. See also Supplementary
Figure S1A. (B) Absolute expression levels measured by RNA sequencing of genes associated with pluripotency or lineage priming, in Stat3þ /þ
and Stat3 / cells. RPKM (Reads Per Kilobase per Million mapped reads) is a normalized unit of mRNA expression. (C) Morphology of Stat3þ /þ
and Stat3 / cells in 2i culture. Both cell lines show homogeneous morphology with no sign of spontaneous differentiation. Scale bar, 100mm.
(D) Clonogenicity assay on Stat3þ /þ and Stat3 / cells. Three hundred cells per well were plated in 2i on laminin-coated plates and stained for
alkaline phosphatase (AP) after 5 days. Bars show the number of AP-positive colonies obtained. Mean and s.d. of two independent experiments is
shown.
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self-renew (Ying et al, 2008) because they are non-responsive
to LIF, indicating that activation of Stat3 cannot be
substituted by alternative mediators.
Identiﬁcation of Stat3 direct targets in mouse ES cells
Nonetheless, LIF is known to activate PI3 kinase and Erk
signalling in addition to Stat3 (Burdon et al, 1999). It is also
known that LIF enhances self-renewal efﬁciency in all ES cell
culture conditions, including 2i (Wray et al, 2010). We
therefore tested whether LIF has any additive effect on self-
renewal of Stat3 null cells. As previously observed, LIF
increased the colony-forming efﬁciency of wild-type cells
(Figure 2A). However, Stat3 null cells showed no response,
further verifying the primary role of Stat3 in mediating the
contribution of LIF to ES cell self-renewal.
The existence and developmental potency of Stat3 null ES
cells highlights the regulative nature of the naı¨ve pluripo-
tency network (Nichols and Smith, 2012). This ﬂexibility
creates the opportunity for manipulating the extrinsic
environment to delineate the functional contributions of
individual components (Martello et al, 2012). Accordingly,
we exploited these mutant ES cells to deﬁne genes that are
directly induced by activation of Stat3 rather than other
signals downstream of LIF receptor. We exposed wild-type
and Stat3 null cells to LIF for 1 h and prepared RNA for
transcriptome analysis by deep sequencing. The short period
of LIF stimulation is expected to enrich for primary
transcriptional targets. We found that 188 genes were
induced in Stat3 wild-type cells (Figure 2B, orange), and
among these only 5 were induced in Stat3 null cells
(Figure 2B, green). This indicates that the majority of genes
acutely responsive to LIF require Stat3 for induction. We then
used published Stat3 ChIP-seq (chromatin immunoprecipita-
tion followed by massively parallel sequencing) data (Chen
et al, 2008) to generate a list of genes (see Materials and
methods) bound, and thus potentially directly regulated, by
Stat3 (top panel of Figure 2B, purple). This yielded 3935
unique genes, representing B17% of all annotated genes.
Signiﬁcantly, a high proportion of genes induced by LIF in
Stat3 wild-type cells were also bound by Stat3 (38.8%,
P-value¼ 3.41014). In contrast, Stat3-bound genes were
signiﬁcantly underrepresented among those induced by LIF in
Stat3 null cells (1.9%, P-value¼ 0.0094). We performed a
similar analysis on genes downregulated after LIF stimulation
(bottom panel of Figure 2B), and found that Stat3-bound genes
were underrepresented (11.2%, P-value¼ 0.003). These results
are consistent with the characterized role of Stat3 as a tran-
scriptional activator (Boeuf et al, 1997; Darnell, 1997).
Accordingly, we focussed on genes induced by LIF in wild-
type cells (Figure 2C and D), and selected those involved in
the regulation of transcription, such as transcription factors
or chromatin modiﬁers. We performed gene expression ana-
lysis by qRT-PCR on a set of 13 genes and validated 6 to be
induced after LIF stimulation (Figure 2D). Induction of the
remaining seven genes could not be conﬁrmed because they
are expressed at low levels and thus were difﬁcult to quantify
reliably by qRT-PCR. Among these six genes are Stat3 itself
and other genes previously identiﬁed as Stat3 direct targets
(Bourillot et al, 2009). Interestingly, however, the most highly
expressed transcription factor in this group, Tfcp2l1 (also
known as Crtr-1), has not previously been linked to LIF
signalling. We therefore tested whether Tcfp2l1 is indeed
directly responsive to LIF by stimulating cells in the
presence of the protein synthesis inhibitor cycloheximide
(Figure 2F). Induction was unaffected, conﬁrming that
Tfcp2l1 is a primary target of LIF signal transduction.
We then tested dependence on LIF for sustained expres-
sion. For this, we cultured ES cells under serum-free condi-
tions in the presence of LIF and the Mek inhibitor PD0325901
(PD), then withdrew LIF and added a JAK kinase inhibitor
(JAKi) to block LIF signalling completely. We analysed the
expression of the six Stat3 targets over time and found that,
with the exception of Gbx2, all genes were downregulated
upon removal of the LIF signal (Figure 2G). Expression of
Klf4, Pim1, Prr13, Stat3, and Tfcp2l1 therefore directly corre-
lates with LIF stimulation, whereas Gbx2 expression is
responsive to LIF (Figure 2D and E) but can be maintained
by additional mechanisms.
Tfcp2l1 is the major effector of self-renewal
downstream of Stat3
LIF, in combination with serum, maintains ES cell self-renewal.
Therefore, omitting Stat3 itself, we tested whether the identi-
ﬁed targets could confer self-renewal in serum without LIF.
We used Rex1GFPd2 reporter cells to monitor uncommitted
status (Marks et al, 2012; Martello et al, 2012) and transfected
these with piggyBac expression vectors (Guo et al, 2009).
Following hygromycin selection for two passages, we
tested the response to LIF withdrawal in the presence of
serum. Empty vector (PB-Vector)-transfected cells rapidly
downregulated the GFP reporter and differentiated
(Figure 3A; Supplementary Figure S1B). This was unchanged
in Pim1 and Prr13 transfectants. Klf4 and Gbx2 expression
maintained a proportion of ES cells in a morphologically
undifferentiated state for several passages, and this was
reﬂected in persistent expression of the Rex1-GFP reporter.
However, Tfcp2l1 transfectants showed a stronger suppres-
sion of differentiation and maintenance of Rex1GFP, compar-
able to continuous culture in LIF (Figure 3A, compare top-left
and bottom-right ﬂow proﬁles). We also examined self-re-
newal capacity at the single-cell level by colony forming
assay (Figure 3B). Gbx2 and Klf4 transfectants produced
some undifferentiated colonies in the absence of LIF, consis-
tent with previous reports (Hall et al, 2009; Niwa et al, 2009;
Tai and Ying, 2013), but many more colonies were obtained
from Tfcp2l1 transfectants.
Klf4 and Gbx2 have previously been identiﬁed as factors
promoting self-renewal downstream of LIF. However, the
preceding data suggest that Tfcp2l1 has more potent self-
renewal activity. LIF also supports self-renewal in serum-free
conditions when combined with Mek inhibition (PD) (Wray
et al, 2010). We found that Tfcp2l1 expression conferred long-
term self-renewal capacity under serum-free conditions in the
presence of PD without LIF (Figure 3C, see also Figure 4).
Thus, overexpression of Tfcp2l1 largely recapitulates LIF
stimulation in different culture conditions.
We then tested which target genes are required for LIF-
responsive ES cell self-renewal by knockdown using a dox-
ycycline (DOX)-inducible shRNA system (see Materials and
methods). For each gene, we used two independent shRNA con-
structs with knockdown efﬁciencies 460% (Supplementary
Figure S1C). When cultured in serum-containing media in the
presence of LIF, ES cells transfected with a control shRNA
(shLacZ) gave rise to the same number of colonies in the
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presence or absence of DOX (Figure 3D, ﬁrst bar).
Knockdown of Klf4 or Gbx2 had no effect in agreement
with previous reports showing that suppression of either of
these factors does not markedly impair ES cell self-renewal
(Jiang et al, 2008; Tai and Ying, 2013). In contrast, Tfcp2l1
knockdown caused a marked decrease in the number of ES
cell colonies (Figure 3D). Similar results were obtained in
LIF/PD (Figure 3E). Furthermore, Tfcp2l1 depletion in bulk
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culture in presence of LIF precipitated differentiation
(Figure 3F, middle and bottom panels, see also
Supplementary Figure S1F). Consistent with this, gene ex-
pression analysis after 4 days of shTcfcp2l1 induction showed
a reduction in mRNA levels of key pluripotency factors,
including Nanog, Oct3/4, Sox2, and Esrrb (Figure 3G).
Signiﬁcantly, however, Tfcp2l1 knockdown was well toler-
ated by ES cells cultured in 2iþLIF (Supplementary Figure
S1D and E), conﬁrming that the phenotype is speciﬁc to LIF-
stimulated self-renewal. These results suggest that Tfcp2l1
exerts a unique function downstream of Stat3 that is neces-
sary for a full self-renewal response to LIF (Figure 3I).
Many naı¨ve pluripotency factors such as Klf4 exhibit
mosaic expression in ES cells cultured in LIF and serum
(Wray et al, 2010). In contrast, we found that Tfcp2l1
protein is widely expressed, with 490% of Oct3/4
expressing cells being Tfcp2l1 positive (Figure 3H and data
not shown). This broad expression may underlie the capacity
of LIF to sustain self-renewal efﬁciently in serum.
As shown above, Tfcp2l1 overexpression can maintain self-
renewal of ES cells in the absence of LIF (Figure 3A–C). In
those experiments, however, Tfcp2l1 transgene mRNA may
be up to three-fold higher than endogenous levels
(Supplementary Figure S1B) which, given that endogenous
Tfcp2l1 transcript is very abundant in ES cells (Figure 2D),
raises the possibility of neomorphic effects. We therefore
used low-dose Hygromycin selection to obtain ES cell trans-
fectants in which Tfcp2l1 transgene expression was restricted
at close to LIF-stimulated endogenous levels (Figure 4A), as
measured by qRT–PCR and immunoblotting (Figure 4B). This
constrained expression of Tfcp2l1 was fully sufﬁcient to
sustain self-renewal after LIF withdrawal, as shown by
undifferentiated morphology (Figure 4C), expression of
pluripotency markers (Figure 4D and F), and capacity to form
AP-positive colonies (Figure 4E).
We then tested whether the effect of Tfcp2l1 on self-renew-
al in these cells was reversible by excising the ﬂoxed Tfcp2l1
transgene after expansion in the absence of LIF for seven
passages (Figure 4A; Supplementary Figure S1G). After exci-
sion, cells differentiated unless maintained in the presence of
LIF (Figure 4C–E). We carried out blastocyst injection with
the excised cells to assay their developmental identify and
potency. As a rigorous test, we injected single cells. We
obtained chimaeras with an efﬁciency of B30%, similar to
the parental ES cell line (Figure 4G, table). Mid-gestation
chimaeras exhibited widespread contribution to all germ
layers (Figure 4G, top panels). Single Tfcp2l1 excised cells
could also give rise to healthy term chimaeras (Figure 4H).
We conclude that constitutive expression of Tfcp2l1 is sufﬁ-
cient to replace LIF and sustains ES cell self-renewal without
transformation or impairment of somatic differentiation po-
tential. Collectively, these results indicate that Tfcp2l1 is the
major effector of self-renewal downstream of Stat3.
Tfcp2l1 sustains self-renewal independently of Stat3
Next, we examined the epistatic relationship between Stat3
and Tfcp2l1. We transfected Stat3 null cells with expression
vectors for Klf4 or Tfcp2l1. After transfection, cells were
cultured in serum-free medium containing PD and the selec-
tion agent hygromycin (Figure 5A). PB-Vector cells rapidly
differentiated or died, as did PB-Klf4 cells and no stable
transfectants were obtained (data not shown). In contrast,
Tfcp2l1 expressing cells expanded efﬁciently and could be
maintained over several passages. They displayed undiffer-
entiated morphology (Figure 5B) and were able to self-renew
at clonal density (Figure 5C). We characterized the Stat3 null
cells expressing Tfcp2l1 by qRT–PCR and found that they
expressed Oct3/4, Sox2, Rex1, and Esrrb at levels similar to
wild-type ES cells in 2i. Reduced Klf4 expression was ob-
served, consistent with the absence of LIF/Stat3 signalling
(Figure 5D). These data suggest that Tfcp2l1, but not Klf4,
can replace Stat3 in ES cell self-renewal.
We then consulted the ES cell ChIP-seq compendium
(http://bioinformatics.cscr.cam.ac.uk/ES_Cell_ChIP-seq_-
compendium.html) to interrogate available ChIP-seq data
sets (Martello et al, 2012). Unsupervised hierarchical
clustering showed that Stat3 and Klf4 genome-wide binding
proﬁles are closely related (Figure 5E). In contrast, Tfcp2l1
has a distinct binding proﬁle and clusters with neither the
‘core’ factors nor Stat3 (Figure 5E). This is consistent with
Tfcp2l1 acting downstream of Stat3 and additive to the ‘core’
factors to sustain ES cell self-renewal (Figure 5B).
Tfcp2l1 mediates induction of pluripotency downstream
of LIF/Stat3
LIF signalling through Stat3 plays a key role in induction of
pluripotency. Activation of LIF/Stat3 is required for iPS cell
formation (Tang et al, 2012; van Oosten et al, 2012), and is
sufﬁcient to reprogram post-implantation EpiSCs to naı¨ve
pluripotency (Yang et al, 2010). It is not known, however,
whether the target genes that sustain self-renewal are the
same as those that mediate reprogramming. To identify Stat3
Figure 2 Identiﬁcation of Stat3 primary targets in mouse ES cells. (A) Clonogenicity assay. Six hundred cells per well were plated either in 2i or
in 2iþLIF on laminin-coated plates and stained for alkaline phosphatase (AP) after 5 days. Bars show the number of AP-positive colonies
obtained. Mean and s.d. of three independent experiments is shown. (B) Top: Venn diagram showing overlap between genes upregulated
(P-valueo0.05) after 1 h of LIF treatment in Stat3þ /þ cells (orange), in Stat3 / cells (green) and genes bound by Stat3 (see Materials and
methods). Bottom: Venn diagram showing overlap between genes downregulated (P-valueo0.05) after 1 h of LIF treatment in Stat3þ /þ cells
(orange), in Stat3 / cells (green) and genes bound by Stat3. (C) Flow chart illustrating the approach used to identify candidate genes that
mediate self-renewal downstream of Stat3. See also Supplementary Table S1. (D) Absolute expression of the 13 genes identiﬁed as potential
mediators of Stat3 activity in ES cells. Blue bars indicate expression in 2i and red bars indicate expression after 1 h of LIF treatment in 2i.
(E) Gene expression analysis of ES cells cultured in 2i and treated with LIF for 1 h. Beta-actin served as an internal control. Mean and s.d. of two
independent experiments is shown. (F) Gene expression analysis of ES cells cultured in 2i after LIF stimulation for 1 and 4h in the presence of
the protein-synthesis inhibitor Cycloheximide (CHX). Cells were expanded in 2i without LIF and treated with LIF for 1 or 4 h, in the presence of
either CHX (50mm/ml, blue bars) or DMSO (vehicle, orange bars). CHX or DMSO was added to the medium 30min before LIF treatment, and
maintained throughout the experiment, to ensure effective inhibition of protein synthesis. Beta-actin served as an internal control and data are
normalized to unstimulated 2i cultures. Mean and s.d. of four biological replicates is shown. (G) Gene expression analysis of ES cells cultured
under serum-free conditions in the presence of LIF and the Mek inhibitor PD0325901 (PD). LIF was withdrawn and the Jak inhibitor (1mM) was
applied for the indicated time. Beta-actin served as an internal control. Mean and s.d. of two independent experiments is shown.
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vector containing Gbx2, Klf4, Pim1, Prr13, and Tfcp2l1 or no cDNA (PB-Vector); transfected cells were selected for two passages with
Hygromycin in LIFþ serum. Only PB-Gbx2, PB-Klf4, and PB-Tfcp2l1 cells showed sustained self-renewal in the absence of LIF, expanding
continuously for 410 passages. The dashed line separates GFP-positive and GFP-negative cells and the percentage of GFP-positive cells is
indicated. See also Supplementary Figure S1B. (B) Clonogenicity assay in serum. The indicated cell lines were plated at clonal density in serum
containing media either in the presence (LIFþSerum) or in the absence (Serum) of LIF, and stained for alkaline phosphatase (AP) after 5 days.
Bars show the number of APþ colonies obtained. Mean and s.d. of three independent experiments is shown. (C) Self-renewal in serum-free
culture. PB-Vector and PB-Tfcp2l2 cells (described in Figure 3A) were cultured in the presence of LIF and the Mek inhibitor PD. After LIF
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inducible shRNA constructs targeting the indicated genes were stably transfected in Rex1-GFPd2 cells (see Materials and methods). An shRNA
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(F) Morphology of the indicated shRNA lines cultured in LIF either in the absence or in the presence of DOX for 4 days. Knockdown of Tfcp2l1
resulted in differentiation. Scale bar, 100mm. See also Supplementary Figure S1F. (G) Gene expression analysis of the indicated shRNA lines
cultured in LIFþPD condition, either in the absence or in the presence of DOX for 4 days. Beta-actin served as an internal control and data are
presented as ratios of þDOX and –DOX conditions. Mean and s.d. of two independent biological replicates is shown. (H) Fluorescence micrographs
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Figure 4 Forced expression of Tfcp2l1 maintains pluripotency. (A) Experimental scheme for testing the sufﬁciency of Tfcp2l1 forced
expression for the maintenance of ES cell pluripotency. (B) Top: western blot of Rex1GFPd2 cells transfected with an empty vector (PB-
Vector) cultured in 2iþLIF, and PB-Tfcp2l1 cells cultured in PD for ﬁve passages. For each line, two biological replicates were loaded. GAPDH
served as a loading control. Bottom: qRT-PCR analysis of total Tfcp2l1 expression of the indicated cell lines. Note that Tfcp2l1 is rapidly
downregulated in PB-Vector cells cultured in PD alone. Beta-actin served as an internal control. (C) Representative pictures of PB-Vector and
PB-Tfcp2l1 under the indicated culture conditions. Note that after excision of the transgene (PB-Tfcp2l1 excised) PB-Tfcp2l1 cells behave as PB-
Vector cells. Scale bar, 100 mm. (D) Flow cytometry analysis of control (PB-Vector) and Tfcp2l1 expressing (PB-Tfcp2l1) cells under the
indicated culture conditions. The dashed line separates GFP-positive and GFP-negative cells. (E) Clonogenicity assay of PB-Vector and PB-
Tfcp2l1 cells before and after transgene excision. Note that PB-Tfcp2l1 cells behave as PB-Vector cells after excision of the Tfcp2l1 transgene
(PB-Tfcp2l1 excised). Mean and s.d. of two independent biological replicates is shown. (F) Gene expression analysis of PB-Vector and PB-
Tfcp2l1 cells cultured in the indicated conditions. Beta-actin was used as an endogenous control and data are normalized to PB-Vector cells
cultured in 2iþLIF media. (G) Single-cell blastocyst injection. PB-Tfcp2l1 excised cells and Rex1GFPd2 cells were labelled with a constitutive
GFP transgene (PB-GFP); single GFP-labelled cells were injected into blastocyst stage embryos; embryos were scored at mid-gestation (E12.5)
for the presence of GFP-positive cells. Top: representative picture of chimaeric embryos derived after injection of single PB-Tfcp2l1 excised
cells. The embryo on the right showed no chimaerism and serves as a control for GFP signal. Bottom: table summarizing the results obtained
from two independent sections of injection. (H) Adult chimaeric animal showing widespread coat-colour contribution generated by single-cell
blastocyst injection. Source data for this ﬁgure is available on the online supplementary information page.
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targets active during reprogramming, we used embryo-
derived EpiSCs that stably express a chimaeric gp130
receptor, GY118F, which elicits hyperactivation of
endogenous Stat3 in response to granulocyte colony
stimulating factor (GCSF) (Burdon et al, 1999; Yang et al,
2010). Exposure of these EpiSCs to GCSF for 48 h in 2i is
sufﬁcient to induce formation of a modest number of
reprogrammed colonies (Figure 6B, see also Yang et al,
2010). Importantly, exposing EpiSCs to LIF is not effective,
suggesting that activation of Stat3 is limiting for induction
of key target gene(s) to a level sufﬁcient to drive
reprogramming. We examined expression of a panel of
candidate genes in EpiSCs exposed to either 2iþLIF or
2iþGCSF for 48 h in comparison with EpiSCs cultured in
FGF2 and Activin A (F/A). We also included ES cells cultured
in 2iþ LIF as a reference. We chose 30 Stat3 targets, based on
the present and previous studies (Bourillot et al, 2009), and
determined their expression by qRT–PCR. We searched for
genes that were induced in EpiSCs and, more speciﬁcally,
were upregulated to higher levels in 2i/GCSF compared to
2iþ LIF (Figure 6C, compare the second to the ﬁrst column in
the heatmap). Interestingly, we found that Klf4 and Myc, two
reprogramming factors previously reported as Stat3 targets,
were not induced by GCSF in EpiSCs, whereas four transcrip-
tion factors, Klf5, Gbx2, Pim1, and Tfcp2l1, were upregulated
to levels comparable to, or higher than, their expression in ES
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Figure 5 Tfcp2l1 can replace Stat3 in ES cell self-renewal. (A) Experimental scheme for testing the ability of Tfcp2l1 and Klf4 to maintain self-
renewal in Stat3 / ES cells. (B) Representative pictures of PB-Tfcp2l1 transfected Stat3 / ES cells cultured in PD for four passages. Two
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presence of PD. Beta-actin was used as an endogenous control and data are normalized to the highest value. The Stat3 primers are designed to
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exogenous Tfcp2l1 transcript. Mean and s.d. of three independent replicates is shown. (E) Hierarchical clustering of 11 genome-wide binding
maps from the Mouse ES cell ChIP-seq Compendium. Hierarchical clustering and Pearson correlation coefﬁcients were used to display all
pairwise comparisons in a clustered heatmap. Colours in the heatmap show the level of correlation for all pairwise comparisons (orange¼ 1;
white¼ 0.5, green¼ 0). Factors have been clustered along both axes according to the level of correlation. Note that, as previously reported, the
‘core’ factors Oct3/4, Sox2, and Nanog cluster together; Klf4 clusters together with Stat3 whereas Tfcp2l1 has a distinct binding proﬁle.
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cells (Figure 6C, blue box in the heatmap and histograms).
We tested whether induction of these four Stat3 targets was
required for reprogramming by knockdown. We performed
siRNA transfection followed by GCSF stimulation and scored
the number of Oct4-GFP-positive colonies after 4 days in
2iþ LIF (Figure 6D, top). Stat3 knockdown resulted in aB10-
fold reduction, conﬁrming that Stat3 mediates induction of
pluripotency downstream of the chimaeric GCFS/gp130 re-
ceptor. We found that knockdown of Gbx2 and Klf5 had no
effect, and knockdown of Pim1 resulted in a B2-fold de-
crease in colony number. However, Tfcp2l1 ablation substan-
tially reduced the number of colonies recovered. This
suggests that Tfcp2l1 plays a critical role in induction of
naı¨ve pluripotency downstream of Stat3.
We then tested whether Tfcp2l1 expression is sufﬁcient to
convert EpiSCs into naı¨ve pluripotency. We found that Oct4-
GFP reporter EpiSCs (O4GIP) stably transfected with a
Tfcp2l1 expression vector efﬁciently converted into naı¨ve
pluripotency when exposed to 2i (Figure 6E). Importantly,
addition of LIF resulted in only a modest further increase in
the number of colonies, suggesting that forced expression of
Tfcp2l1 could largely recapitulate the contribution of LIF to
EpiSC reprogramming. The reprogrammed colonies obtained
could be passaged in 2iþLIF and gave rise to stable iPS cell
lines (Figure 6F). Gene expression analysis conﬁrmed acti-
vation of the naı¨ve markers Tbx3 and Esrrb and downregula-
tion of the EpiSC markers Fgf5 and Sox17 (Figure 6G).
EpiSCs are variable and one line (GOF18) derived on
feeders in the presence of FGF2 has been reported to convert
spontaneously to naı¨ve pluripotency when exposed to
2iþ LIF (Han et al, 2010). We found that GOF18 cells
retained this ability even after prolonged culture under
feeder-free conditions in the presence of FGF2 and Activin
A. The conversion frequency in 2i alone was extremely low,
but was greatly increased by addition of LIF (Supplementary
Figure S2A). Moreover, we found that addition of LIF for only
the ﬁrst 48 h gave rise to the same number of colonies as
continuous exposure (Supplementary Figure S2A, compare
second and third bar). Therefore, we measured the expres-
sion of Stat3 targets by qPCR in GOF18 cells exposed to either
2i or 2iþ LIF for 48 h. Both Gbx2 and Tfcp2l1 were expressed
in these EpiSCs in 2i, but signiﬁcantly only Tfcp2l1 was
further upregulated by LIF (Supplementary Figure S2B). We
transiently transfected GOF18 cells with a Tfcp2l1 expression
vector and 24 h after transfection replated them in 2i without
LIF. After 6 days, we scored the number of Oct4-GFP-positive
colonies. We observed an B10-fold increase in colony for-
mation after Tfcp2l1 transfection (Supplementary Figure S2C,
left), indicating that a transient increase in Tfcp2l1 expression
is sufﬁcient to drive the reprogramming process. The iPS cells
generated after Tfcp2l1 expression could be expanded in
2iþ LIF over multiple passages, showing undifferentiated
morphology, stable expression of the Oct4-GFP reporter
(Supplementary Figure S2C, right panels) and of naı¨ve
pluripotency markers, and a concomitant reduction in EpiSC
markers (Supplementary Figure S2D).
We analysed data on a panel of EpiSC lines (Bernemann
et al, 2011) and found no signiﬁcant differences in expression
of LIF/Stat3 pathway components between lines that convert
spontaneously and lines that do not (Supplementary Figure
S2E, compare red and blue bars). We also found that both
O4GIP and GOF18 cells express Tfcp2l1 mRNA at similar very
low levels (Supplementary Figure S2F). Moreover, Tfcp2l1
protein 1 could not be detected by immunoﬂuorescence in
GOF18 cells, excluding the possibility of a rare sub-popula-
tion of expressing cells (Supplementary Figure S2G). We
conclude that spontaneous conversion into naı¨ve pluripo-
tency does not correlate with increased Tfcp2l1 expression in
the EpiSC state, but rather with the ability to activate Tfcp2l1.
Finally, to conﬁrm functional naı¨ve pluripotent status after
Tfcp2l1-mediated reprogramming, we transfected O4GIP-
derived iPS cells with a constitutive GFP expression vector,
excised the Tfcp2l1 transgene by Cre plasmid transfection,
and carried out blastocyst injection. Two out of six trans-
ferred embryos showed widespread GFP expression at mid-
gestation (Figure 6H). Taken together, these results suggest
that Tfcp2l1 plays a major role downstream of LIF/Stat3 in
the conversion of EpiSCs into authentic naı¨ve pluripotency.
Discussion
The LIF/Stat3 pathway plays crucial facultative roles in
mouse ES cell self-renewal (Smith et al, 1988; Williams
et al, 1988; Niwa et al, 1998), maintenance of pluripotent
epiblast during embryonic diapause (Nichols et al, 2001),
generation of EG cells (Leitch et al, 2013), and molecular
induction of pluripotency (Yang et al, 2010; Tang et al, 2012;
van Oosten et al, 2012). How LIF input is integrated with
the pluripotency gene regulatory network has remained
unclear, however (Niwa et al, 1998, 2009; Nichols and
Smith, 2012). cMyc has been proposed as a mediator
(Cartwright et al, 2005), but neither cMyc nor NMyc are
appreciably induced by LIF in ES cells (Hall et al, 2009). Klf4
has been shown to be a direct target of Stat3 (Li et al, 2005;
Hall et al, 2009; Niwa et al, 2009), but is neither required nor
sufﬁcient to account for the potent effects of LIF stimulation.
A signiﬁcant role for alternative modes of LIF signalling has
also been invoked, either through PI3 kinase (Welham et al,
2007; Niwa et al, 2009) or by JAK modiﬁcation of chromatin
(Grifﬁths et al, 2011).
To resolve this issue, we ﬁrst conﬁrmed that Stat3 null cells
have functional ES cell identity and potency yet show no self-
renewal response to LIF. We then sought the missing target(s)
of Stat3 and identiﬁed the transcription factor Tfcp2l1.
Tfcp2l1, also known as Crtr1, has previously been described
in ES cells (Pelton et al, 2002; Ivanova et al, 2006; Chen et al,
2008), but its relationship to LIF/Stat3 has gone unnoticed.
Tfcp2l1 is regulated directly by activated Stat3 and induced to
high levels. Gain- and loss-of-function perturbations
established that Tfcp2l1 is both necessary and largely
sufﬁcient to mediate the effects of LIF on ES cell self-
renewal in either serum or serum-free culture conditions, in
contrast to previously identiﬁed targets, Klf4, Gbx2, and
Pim1. Strikingly, forcing expression of Tfcp2l1 at close to
endogenous levels was sufﬁcient to phenocopy LIF
stimulation. Finally, we showed that Tcfcp2l1 is epistatic to
Stat3 in sustaining ES cell self-renewal (Figure 5). From these
results, we conclude that Tfcp2l1 is the major mediator of ES
cell self-renewal downstream of LIF/Stat3, and that it exerts
functions that cannot be compensated by other LIF targets.
We previously noted that Tfcp2l1 is also induced by GSK3
inhibition (Martello et al, 2012). It may therefore constitute
the postulated point of intersection between these two
mechanisms for supporting ES cell self-renewal (Hao et al,
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2006; Ogawa et al, 2006; Wray et al, 2010). Notably, however,
while Tfcp2l1 appears sufﬁcient to replace LIF/Stat3, it
cannot reproduce the full effect of GSK3 inhibition (Figure 3A
in Martello et al, 2012).
We also investigated mediators of LIF/Stat3 action during
reprogramming. Klf4 is a canonical reprogramming factor
(Takahashi and Yamanaka, 2006). However, LIF is required
for efﬁcient reprogramming of both somatic cells and EpiSCs
even when Klf4 is overexpressed (Yang et al, 2010; Tang et al,
2012), suggesting a requirement for other LIF/Stat3 target(s).
Analysis of the initial phase of EpiSC reprogramming did not
show induction of known reprogramming factors such as Klf4
and cMyc, consistent with previous observations (Yang et al,
2010). In contrast, Gbx2, Klf5, Pim1, and Tfcp2l1 were
induced (Figure 6C). Transient expression of Tfcp2l1 was
sufﬁcient to convert EpiSCs into naı¨ve pluripotency without
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LIF stimulation, while Tfcp2l1 knockdown caused a dramatic
reduction in reprogramming efﬁciency (Figure 6D).
Importantly, when Tfcp2l1 is knocked down in ES cells in
2iþ LIF there was no signiﬁcant compromise to self-renewal
(Supplementary Figure S1D and E). This suggests that
Tfcp2l1 has a speciﬁc role in resetting of naive pluripotency
in addition to its action in self-renewal.
Tfcp2l1 is a member of the CP2 family of transcription
factors, which are generally considered to be activators of
transcription (Lim et al, 1993; Bing et al, 1999). This has been
demonstrated for Tcfp2l1 in ES cells (To et al, 2010), although
in some contexts it may act as a repressor (Rodda et al, 2002).
Interestingly, genome location data indicate that Tbx3, Esrrb,
and Nanog are bound by Tfcp2l1 (data from Chen et al, 2008
and ES cell ChIP-seq Compendium) and upon Tfcp2l1
knockdown we noted downregulation of the three genes
(Figure 3G). Similar effects of Tfcp2l1 depletion are also
apparent in data from a recent microarray study
(Nishiyama et al, 2013; Supplementary Figure S3A and B).
Furthermore, we observed that upon overexpression of
Tfcp2l1, Tbx3 and Nanog are signiﬁcantly upregulated
(Figure 6G; Supplementary Figures S2D, S3A and B and
data not shown). These observations suggest that Tfcp2l1
sustains ES cell self-renewal in large part through transcrip-
tional activation of Nanog and Tbx3, both of which have been
proposed to lie genetically downstream of LIF (Niwa et al,
2009) but neither of which are direct targets (Bourillot et al,
2009; Hall et al, 2009).
Tfcp2l1 is expressed in the inner cell mass of the mouse
blastocyst and is downregulated shortly after implantation
(Pelton et al, 2002; Guo et al, 2010). It is rapidly
downregulated when ES cells start to differentiate (Ivanova
et al, 2006) and is absent from mouse EpiSCs (Figure 6) in
common with other naı¨ve pluripotency markers such as
Esrrb, Rex1, and Klf2/4 (Tesar et al, 2007; Nichols and
Smith, 2012). Human pluripotent ES cells are considered to
be in a primed pluripotent state closer to mouse EpiSCs than
ES cells. Tfcp2l1 is detected in the human ICM, but
downregulated during derivation of human ES cells
(O’Leary et al, 2012). Human ES cells have been reported to
convert into a naı¨ve-like state by overexpression of Klf2, Klf4,
and Oct3/4 (Hanna et al, 2010). Interestingly, inspection of
the microarray data from that study reveals that Tfcp2l1 is
highly upregulated. It is possible therefore that Tfcp2l1 may
play a role in generating and stabilizing a human naı¨ve
pluripotent state.
LIF is a stimulus that confers self-renewal and can promote
emergence of the naı¨ve pluripotent gene regulatory network,
but is not itself integral to pluripotent identity (Nichols et al,
2001; Smith, 2001; Ying et al, 2008; Nichols and Smith, 2012).
Consistent with this, Tfcp2l1 genome occupancy does not
cluster with that of canonical pluripotency factors Oct4, Sox2,
and Nanog. Instead, it binds to a largely distinct, and broad,
set of genes. Signiﬁcantly, however, these targets include key
naı¨ve pluripotency factors Nanog and Tbx3 previously shown
to support ES cell self-renewal (Chambers et al, 2003;
Ivanova et al, 2006; Niwa et al, 2009). Furthermore, the
Tfcp2l1 promoter is bound by Oct4, Sox2, Nanog, Esrrb,
and Klf4 (ES cell ChIP-seq compendium), and is targeted by
the pluripotency repressor Tcf3 (Martello et al, 2012),
indicating that Tfcp2l1 is hard-wired into the pluripotency
gene regulatory network. We conclude that Tfcp2l1 is a
previously overlooked transcriptional regulator that plays a
pivotal role in the capability to generate, derive, and
propagate naı¨ve pluripotent stem cells. Although mutation
of Tfcp2l1 is reported to be compatible with mouse embryo
development, the characterized gene trap mutation may not
create a null allele since residual full-length transcript is
detectable (Yamaguchi et al, 2005). It will therefore be of
interest to determine the effects of complete deletion of
Tfcp2l1 on the emergence of pluripotency in the blastocyst,
and epiblast maintenance during diapause when the Stat3
pathway is indispensable (Nichols et al, 2001).
Materials and methods
RNA-seq library construction
RNA was extracted using the TRIzol method (Invitrogen) followed
by treatment with TURBO DNase (Ambion). Ribosomal RNA was
depleted using RiboMinus (Invitrogen), and the remaining RNAwas
sheared by ultrasonication on a Covaris S2 for 90 s with the
Figure 6 Tfcp2l1 mediates resetting of naive pluripotency. (A) Experimental scheme used to identify genes activated by the chimaeric GCSF/
LIF-R receptor (GY118F) during EpiSC reprogramming. (B) Number of Oct4-GFP colonies obtained from O4GIP cells 6 days after induction of
reprogramming. Note that activation for 48 h of the chimaeric GCSF/LIF-R receptor is sufﬁcient to convert EpiSCs efﬁciently to ground-state
pluripotency. (C) Left: heatmap showing the relative expression of the indicated genes in EpiSCs exposed to either 2iþLIF for 48 h (ﬁrst
column) or 2iþGCSF (second column); as a reference the expression in mouse ES cells is shown (third column). The fold change expression
relative to EpiSCs cultured in bFGF and Activin A condition (F/A) is shown and beta-actin serves as an internal control. Right: histograms
showing the relative expression of selected Stat3 targets. Stat3 itself and Socs3 served as positive controls, whereas Gbx2, Klf5, Pim1, and
Tfcp2l1 were chosen for further functional validations. (D) Top: experimental scheme for testing the role of the indicated genes in the process of
reprogramming. O4GIP EpiSCs expressing the chimaeric GCSF/LIF-R receptor were transfected with the indicated siRNAs in bFGF and Activin
A media; after 16 h, they were exposed to GCSF in 2i media for 48 h, followed by 4 days of culture in 2iþLIF media. Bottom: Histogram
showing the number of Oct4-GFP-positive colonies obtained relative to siGFP-transfected cells. Mean and s.d. of three independent
experiments is shown. *Po0.01 (t-test) compared to siGFP control. (E) O4GIP EpiSCs were transfected with PB-Tfcp2l1 and an empty
piggyBac vector control (PB-Vector) in bFGF and Activin A media; after 3 days of Hygro selection, transfectants were replated at low density
and cultured in either 2i or 2iþLIF media for 6 days; the number of Oct4-GFP-positive colonies is shown as mean and s.d. of three independent
experiments. Similar results were obtained by transient transfection of PB-Tfcp2l1 with no selection. (F) Representative pictures of primary
Oct4-GFP colonies emerged after 5 days of reprogramming (left) and of a stable iPS line generated after PB-Tfcp2l1 transfection. Scale bar,
100 mm. (G) Gene expression analysis of parental O4GIP EpiSCs (orange), PB-Tfcp2l1 iPS cells (light blue), and wild-type ES cells (blue).
Beta-actin was used as an endogenous control and data are normalized to the highest value. Mean and s.d. of two independent biological
replicates is shown. (H) O4GIP iPS cells were transfected with a constitutive GFP expression plasmid and injected into blastocyst stage embryos
after excision of the Tfcp2l1 transgene; embryos were scored at E12.5 for the presence of GFP-positive cells and two embryos out of six showed
widespread chimaerism. One of these chimaeras is shown. The embryo on the right showed no chimaerism and served as a control for GFP
signal. (I) Schematic diagram of LIF/Stat3 input to the pluripotency network. Among several transcription factor mediators Tfcp2l1 is of
paramount importance and is uniquely required to promote self-renewal through integration into the core pluripotency gene regulatory
network. Grey lines represent generic interconnectivity between core factors.
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following parameter settings: Duty Cycle¼ 10, Cycles per
Burst¼ 200, Intensity¼ 5. Fragmented RNAwas reverse-transcribed
with SuperScript III (Invitrogen) at 501C for 2 h using random
hexamer and oligo-dT primers (10:1) in the presence of 6mg/ml
actinomycin D to inhibit the generation of second-strand products.
Second-strand cDNA was synthesized by DNA Polymerase I for 2 h
at 161C in the presence of RNase H and with dUTPs substituted for
dTTPs. End repair of double-strand cDNAs was carried out with T4
DNA polymerase and T4 polynucleotide kinase (New England
Biolabs). Blunt-end, 30-phosphorylated products were 30-adenylated
by exo-Klenow fragment in the presence of dATPs and ligated to
sequencing adapters (Illumina) by T4 DNA ligase (New England
Biolabs) at 201C for 30min. Following adapter ligation, the second
strand of the library constructs was digested with uracil DNA
glycosylase (UDG) and apurinic/apyrimidinic endonuclease 1
(APE 1) for 30min at 371C. PCR ampliﬁcation of ﬁrst-strand library
constructs was carried out with Phusion DNA polymerase
(Finnzymes) for 15 cycles. Puriﬁcation of reaction products be-
tween each step was performed with Ampure XP paramagnetic
beads (Beckman Coulter). The molarity and size distribution of the
libraries was assessed by DNA 1000 microﬂuidic chips on the
Agilent 2100 Bioanalyzer. Sequencing was performed on the
Illumina GAIIx yielding 35–40M 105bp reads per sample. RNA-
seq data are available in the ArrayExpress repository under acces-
sion E-MTAB-1796.
RNA-seq data analysis
Reads were aligned to the mouse reference genome (build mm10)
using GSNAP version of 2012-05-24 (Wu and Nacu, 2010). The
aligner was provided with known splice sites based on Ensembl
version 68 (Flicek et al, 2012), but enabled to identify novel splice
sites. A maximum of 10 mismatches were allowed for read
alignment. Gene counts were calculated using the htseq-count
utility (version 0.5.3p3, http://www-huber.embl.de/users/anders/
HTSeq/doc/count.html) and used as an input for differential gene
expression analysis with DESeq version 1.10.1 (Anders and Huber,
2010). Genes with a P-value of o0.05 (Benjamini–Hochberg
adjusted) were selected for further analysis.
ChIP-seq data analysis
We obtained ChIP-seq data for Stat3 and a GFP control from a
previous study (Chen et al, 2008). Reads were mapped to the mouse
genome (build mm10) using bowtie version 0.12.8 (Langmead et al,
2009), discarding non-unique alignments. Peak detection was
performed using MACS version 1.4.1 (Zhang et al, 2008). Each
peak was associated with up to two genes as follows: the most
proximal gene on each strand was identiﬁed by examining 50kb
upstream and downstream of the peak. Peaks were assigned to
intersect genes unless an overlapping gene was found on the
opposite strand. For the heatmap in Figure 5E a binary peak matrix
was generated as described (Martello et al, 2012), analysed by
unsupervised hierarchical clustering using Pearson’s correlation
coefﬁcients, and displayed using the heatmap function in R. The
ChIP-seq data used for target gene intersection in Figure 5F are
Esrrb—GSE11431 (GSM288355) and TFCP2L1—GSE11431. All raw
and processed data used in this study are available at http://
bioinformatics.cscr.cam.ac.uk/ES_Cell_ChIP-seq_compen-
dium.html
ES cell culture
ES cells were cultured without feeders on plastic coated with 0.1%
gelatine (Sigma, cat. G1890) and replated every 3 days at a split
ratio of 1 in 10 following dissociation with Accutase (PAA, cat. L11-
007). Cells were cultured either in the GMEM (Sigma, cat. G5154)
supplemented with 10% FCS (Sigma, cat. F7524), 100mM
2-mercaptoethanol (Sigma, cat. M7522), 1 MEM non-essential
amino acids (Invitrogen, cat. 1140-036), 2mM L-glutamine, 1mM
sodium pyruvate (both from Invitrogen), and 100units/ml LIF, or in
the serum-free media N2B27 (NDiff N2B27 base medium, Stem Cell
Sciences Ltd, cat. SCS-SF-NB-02) supplemented, as indicated, with
small-molecule inhibitors PD (1 mM, PD0325901) and CH (3mM,
CHIR99021) and LIF prepared in-house. Colony forming assays were
carried out by plating 60 ES cells/cm2 on plates coated with laminin
(Sigma, cat. L2020). Plates were ﬁxed and stained for alkaline
phosphatase (Sigma, cat. 86 R-1KT) according to the manufacturer’s
protocol. Plates were scanned using a CellCelector (Aviso) and
scored manually. EpiSCs were cultured as previously described
(Guo et al, 2009). O4GIP (OEC-2 line) was described in
Betschinger et al (2013). GOF18 was described in (Han et al
(2010). For DNA transfection, we used Lipofectamine 2000
(Invitrogen, cat. 11668030) and performed reverse transfection.
For one well of a 6-well plate (10 cm2), we used 6 ml of
transfection reagent, 2 mg of plasmid DNA, and 300000 cells in
2ml of N2B27 medium. The medium was changed after overnight
incubation. The piggyBac vectors used for overexpression followed
by transgene excision have been described in Guo et al (2009). The
transgene is ﬂanked by loxP sites, allowing efﬁcient excision by
transfection with Cre.
Gene expression analysis by quantitative RT–PCR with
reverse transcription
Total RNA was isolated using the RNeasy kit (Qiagen) and 500 ng
used for cDNA synthesis using SuperScript III (Invitrogen) and
oligo-dT primers. Quantitative real-time PCR was carried out
with SYBR green detection. Primers are detailed in Supplementary
Table S2. Technical replicates were carried out for all reactions.
RNAi experiments
siRNAs were transfected at a ﬁnal concentration of 40 nM using
Dharmafect 1 (Dharmacon, cat. T-2001-01), following the protocol
for reverse transfection. For a 12-well plate (4 cm2), we used 2ml of
transfection reagent, 2ml of 20 mM siRNA solution, and 30000 ES
cells in 1ml of N2B27 medium. The medium was changed after
overnight incubation. siRNAs were purchased from Qiagen
(Flexitube GeneSolution, see Supplementary Table S3).
Inducible shRNA
To generate a Dox-inducible shRNA system, we inserted into a
piggyBac vector the murine pre-miR-155 hairpin (from the BLOCK-
IT Pol2 miR RNAi system; Invitrogen) downstream of a third-
generation Tet-responsive promoter (TRE3G). Sequences targeting
the gene of interest (Supplementary Table S4) were cloned into the
miR-155 hairpin by homologous recombination using the Infusion
HD cloning kit (Clontech). The third-generation TET activator
(TET3G) was cloned in a piggyBac vector under control of a
constitutive CAG promoter. Cells were co-transfected with pBase
helper plasmid and the two piggyBac vectors containing both the
TRE3G-shRNA and the TET3G, and cultured in the presence of
selection agent for 7 days prior to experimental assays.
Flow cytometry
After treatment with Accutase, live ES cells were resuspended in
PBS with 3% FCS and 0.05nM ToPro-3 (Invitrogen) was added at a
concentration of 0.05 nM to detect dead cells. Flow cytometry
analyses were performed using a Dako Cytomation CyAn ADP
high-performance cytometer with Summit software.
Immunostaining
Cells were ﬁxed for 10min in 4% PFA at Room Temperature (RT),
permeabilized for 5min in PBSþ 0.2% Triton X at RT, and blocked
for 30min in PBSþ 3% donkey serum at RT. Cells were incubated
overnight at 41C with the primary antibodies (anti-Tcfcp2l1: rabbit
IgG, Abcam 123354, 1:400; anti-Klf4: goat IgG, R&D Systems
AF3158, 1:400; anti-Oct4: mouse IgG, Santa Cruz C-10, used at a
1:300 dilution). After washing in PBS, the cells were incubated with
Alexa Fluor secondary antibodies (Invitrogen, 1:500 in PBSþ
3%serum), for 30min at RT. After DAPI staining, images were
acquired using a Zeiss AxioObserver D1 microscope. Automated
single-cell image quantiﬁcation was performed using CellProﬁle
(Broad Institute—Carpenter et al, 2006).
Immunoblotting
Immunoblotting was performed as previously described in Yang
et al (2010). Antibodies used are rabbit polyclonal anti-Tfcp2l1
(Abcam, AB123354, 1:500 dilution in 1% milk) and mouse
monoclonal anti-GAPDH (Sigma-Aldrich, G8795, 1:1000 in 5%
milk).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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Figure S1 
 
A) GFP-labelled Stat3 -/- ES cells were injected into blastocyst stage embryos and 
gave rise to chimeric animals (4 out of 4 showed widespread GFP signal, 2 
examples are shown).  
B) Gene expression analysis of the indicated genes in the PB transfected cells 
analyzed in Figure 2A. The primers used detect the total levels (endogenous + 
transgenic) of the mRNA of interest, and data are normalized to PB-vector 
transfected cells. Note that the overexpression levels range from 1.5 to 3 fold 
over physiological levels. ActinB was used as endogenous control. 
C) Gene expression analysis of the indicated inducible shRNA lines used in Figure 
3D-G. Cells were cultured in 2i+LIF either in presence (orange bars) or absence 
(blue bars) of Doxycycline (0.1 µg/ml) for 72h. ActinB was used as endogenous 
control and mean and SD of two replicates is shown. 
D) Clonogenicity assay of inducible knock-down ES cell lines in 2i+LIF. DOX-
inducible shRNA constructs targeting the indicated genes were stably 
transfected in Rex1-GFPd2 cells. Cells were plated at clonal density in 2i+LIF 
media either in the presence or absence of DOX and stained for alkaline 
phosphatase (AP) after 5 days. Bars show the ratio between colonies obtained in 
presence and absence of DOX for the indicated shRNA lines. Mean and SD of 2 
independent experiments is shown.  
E) Inducible shTfcp2l1 cells can be cultured in the presence of DOX in 2i+LIF with 
no overt effects on morphology and survival. A representative picture of Rex1-
GFPd2 shTfcp21_2 cells cultured for 3 passages in 2i+LIF +DOX is shown. 
F) Morphology of the indicated shRNA lines cultured in N2B27 media supplemented 
with LIF, either in the absence or in presence of DOX for 3 days. Knockdown of 
Tfcp2l1 resulted in differentiation (white arrows) with minimal cell death. Similar 
results were obtained under LIF + Serum culture conditions. Scale bar, 100µm. 
G) Gene expression analysis of parental ES cells transfected with an empty 
piggybac vector (PB-Vector), Tfcp2l1 expressing cells (PB-Tfcp2l1) and Tfcp2l1 
expressing cells after excision of the transgene (PB-Tfcp2l1 excised). The levels 
of exogenous Tfcp2l1 expression were measured using primers specifically 
recognising the Tfcp2l1 transgene. Gapdh was used as internal control. 
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A) GOF18 EpiSCs (Han et al, 2010) were cultured on fibronectin coated plates, 
without feeders, in bFGF/ActivinA media; after plating at low density they were 
exposed to the indicated culture conditions and after 6 days the number of Oct4-
GFP colonies was counted. Mean and SD of 3 independent experiments is 
shown. Please note that exposure to LIF, either for the first 48h or for 6 days, 
massively increased reprogramming efficiency.  
B) Gene expression analysis of GOF18 EpiSCs cultured in bFGF/ActivinA media 
(F/A), GOF18 cells exposed to 2i or 2i+LIF for 48h and mouse ES cells cultured 
in 2i+LIF. The fold change expression relative to EpiSCs cultured in bFGF and 
ActivinA condition (F/A) is shown and ActinB serves as an internal control. This is 
the same “mouse ES cell 2i+LIF” sample as used in Figure 6C to allow direct 
comparison between the two Figures. 
C) Left: GOF18 EpiSCs were transiently transfected with PB-Tfcp2l1 and an empty 
piggyBac vector control (PB-Vector) in bFGF and ActivinA media; after 1 day they 
were replated at low density and cultured in either 2i media for 6 days; the 
number of Oct4-GFP positive colonies is shown as Mean and SD of 2 
independent experiments. Right: Representative pictures of a stable iPS line 
generated after PB-Tfcp2l1 transfection in GOF18 cells. Scale bar, 100µm. 
D) Gene expression analysis of parental GOF18 EpiSCs (orange) and PB-Tfcp2l1 
iPS cells (light blue) and ES cells cultured in 2i+LIF (dark blue). ActinB was used 
as endogenous control and data are normalized to the highest value. Mean and 
SD of 2 independent replicates is shown. 
E) Gene-expression analysis of 6 EpiSC lines and a mouse ES cell line by 
microarray (data from Bernemann et al, 2011). Three lines (E3, E5 and T9, in 
blue) show spontaneous conversion to naïve pluripotency as the GOF18 line, 
whereas the other three lines (OG2.2, OG2.1 and C1a1) do not convert 
spontaneously (Bernemann et al., 2011). Expression relative to mouse ES cells 
levels is shown on a log2 scale. Note that all EpiSC lines show comparable levels 
of LIF/Stat3 pathway components and target genes. 
F) Gene expression analysis of Tfcp2l1 in GOF18 and O4GIP cells under F/A 
culture conditions and ES cells in 2i+LIF. ActinB served as an internal control and 
data are Mean and SD of 2 biological replicates. 
G) LEFT: Fluorescence micrographs showing immunostaining for Oct3/4 and Tfcp2l1 
in GOF18 EpiSC cells. The insets on the top-right corner of each panel show 
immunostaining of mouse ES cells in LIF+serum and serve as positive controls. 
RIGHT: Distribution of Single-cells measurement of fluorescence intensity in 
GOF18 EpiSCs stained for Oct3/4 and Tfcp2l1. The red dashed lines separate 
positive from negative cells. More than 1400 cells were analyzed and we could 
not observe any Tfcp2l1 positive cell.  
  
 
 
Figure S3 
 
A) Venn diagram showing overlap between genes up-regulated upon Tfcp2l1 over-
expression, downregulated upon Tfcp2l1 knockdown and genes bound by 
Tfcp2l1 (see Supplemental Table 5 for gene lists). Among the 156 putative 
Tfcp2l1 targets we found 3 genes previously involved in mouse ES cell 
pluripotency, namely: Esrrb, Nanog and Tbx3.  
B) Gene expression analysis of Tfcp2l1 and its putative targets upon over-
expression and knockdown of Tfcp2l1 itself. Microarray data (from (Nishiyama et 
al, 2013; Correa-Cerro et al, 2011)) are normalized to control ES cells and shown 
as log2 fold change. 
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TABLE S2 – qPCR primer sequences 
 
 
 
 
Gene 
Name Forward Reverse 
Actb CTAAGGCCAACCGTGAAAAG ACCAGAGGCATACAGGGACA 
Bcor GCTCTGTGCTTGGCGTAATTT CCACTGGATCACGTCCAATA 
cMyc GACCAGATCCCTGAATTGGA CGAAGCTGTTCGAGTTTGTG 
Esrrb GGCGTTCTTCAAGAGAACCA CCCACTTTGAGGCATTTCAT 
Fgf5 AAAACCTGGTGCACCCTAGA CATCACATTCCCGAATTAAGC 
Gbx2 GGCACCTCCTAGATGTGGAC AAAACACTGCAGCTGAGATCC 
Gcnt2 GCCCCATATGCATACACACATAC TCAGTCCAATGACAGCACAAGA 
Gtl2 TGGGCAGGTTTTCTGTCTTC CGACGGAACAAGAGTCCATT 
Klf4 CGGGAAGGGAGAAGACACT GAGTTCCTCACGCCAACG 
Klf5 CCGGAGACGATCTGAAACAC CAGATACTTCTCCATTTCACATCTTG 
Nanog TTCTTGCTTACAAGGGTCTGC AGAGGAAGGGCGAGGAGA 
nMyc AATGGTGCTTAAGTTCCAGC CTTGCAGTCTAATACTGGCC 
Pim1 GCCCTCCTTTGAAGAAATCC GGACCTGGAGTCTGGAATGA 
Pim3 AGCAGTGACCTCTGACCCCT TCAAGTATCCACCCAGGGCA 
Pou5f1 GTTGGAGAAGGTGGAACCAA CTCCTTCTGCAGGGCTTTC 
Prr13 ATCACAAGCACGGGAAGC GAGCTGGTGAGGCTGGAG 
Rex1 TCTTCTCTCAATAGAGTGAGTGTGC GCTTTCTTCTGTGTGCAGGA 
Rtn4 AACCCCTAGCAACTGTGTTT CTGATGTCTGCACTTTCCTCA 
Smad7 ATCCTGTGTGCTGAGCTCTG TGCTCATTGAGCTAAGAACAGT 
Socs2 CACTCCTAGGCGAAGAAGTTGT GTGACTGTGCCATGAAGCAT 
Socs3 ATTTCGCTTCGGGACTAGC AACTTGCTGTGGGTGACCAT 
Sox17 CACAACGCAGAGCTAAGCAA CGCTTCTCTGCCAAGGTC 
Sox2 TCCAAAAACTAATCACAACAATCG GAAGTGCAATTGGGATGAAAA 
Spry2 CACTCCTAGGCGAAGAAGTTGT GTGACTGTGCCATGAAGCAT 
Stat3 GTCCTTTTCCACCCAAGTGA TATCTTGGCCCTTTGGAATG 
Tfcp2l1 GGGGACTACTCGGAGCATCT TTCCGATCAGCTCCCTTG 
Tfcp2l1_TG GTGCTGGTTGTTGTGCTGTC TTGTGCTGGTTGTAGTGTTCG 
Tgtp TGAGAAGAAGGTGGGACCAT GGAAAGCATGAATCCTCTGG 
Trh ATCCCTTCAAGCAAGGAGGT GGAGGATGCGCTGAAGTTATAC 
Vim CCTTTACTGCAGTTTTTCAGG GTATTCTAGCACAAGATTTC 
Zfp36 ATCCTGCCTTAGCCTTTTCC GAGGGAAATTTGAGCACCAG 
Zfp36l1 AATCTTGCCTGGGTTTGTGT CAAAACCTTCGTCCAACTTGT 
 
 
 
 
 
 
 
 
TABLE S3 – siRNA used in this study. 
 
 
Name Cat. from Qiagen  
siGFP 
Custom (target sequence 
GCAAGCTGACCTGAAGTTCA) 
siGbx2 GS14472 
siKlf5 GS12224 
siPim1 GS18712 
siStat3 GS20848 
siTfcp2l1 GS81879 
 
 
 
TABLE S4 – shRNA sequences. 
Name Target sequence 
shKlf4_1 TGTATACTGGGTCCAACTCCG 
shKlf4_2 TATCCATTCACAAGCTGACTT 
shGbx2_1 ATCAGCGAGTCTATGCTGAAG 
shGbx2_2 AAACAGTGGAGTCTGACACGG 
shTfcp2l1_1 ATCAAAGGACCCTCCAACTGC 
shTfcp2l1_2 AATACATCAAAGGACCCTCCA 
